Pille Harrison
About Pille Harrison
Pille Harrison serves as the Vice President of Clinical Development at Alpine Immune Sciences, Inc., where she focuses on developing protein-based immunotherapies for cancer and autoimmune diseases. With extensive experience in rheumatology and clinical research across multiple countries, she has held significant roles in various biopharmaceutical companies and academic institutions.
Work at Alpine Immune Sciences
Currently, Pille Harrison serves as Vice President of Clinical Development at Alpine Immune Sciences, Inc., a position she has held since 2021. In this role, she focuses on the development of protein-based immunotherapies that target the immune synapse for the treatment of cancer and autoimmune diseases. Her leadership in clinical development contributes to advancing the company's innovative therapeutic approaches.
Education and Expertise
Pille Harrison has a robust educational background in medicine and business. She studied at the University of Tartu, where she achieved a Diploma in Medicine and a Certificate of Profession of Rheumatologist. She also completed her MRCP (UK) at the Royal College of Physicians in London. Additionally, she pursued a Global Business Management program at the London School of Business and Finance. Her academic training supports her expertise in rheumatology and immunology.
Background
Pille Harrison has extensive experience in clinical research and development, having worked in both the UK and France. Her career includes various roles in biopharmaceutical companies and academic institutions. She has held leadership positions at organizations such as Sangamo Therapeutics, argenx, and Galapagos, focusing on rheumatology and immunology. Her international experience enhances her contributions to clinical research efforts.
Achievements
Throughout her career, Pille Harrison has contributed significantly to the field of rheumatology through various clinical research and advisory roles. She has been involved in the European Medicines Agency as a member of the Rheumatology/Immunology Working Party and as an alternate member on the Committee for Advanced Therapies. Her work has influenced the development of therapies aimed at treating autoimmune diseases and advancing clinical practices.
Previous Positions
Pille Harrison has held numerous positions in clinical research and development prior to her current role. She worked as Vice President Clinical Research at TxCell and as Senior Medical Director at argenx. Additionally, she served as a Clinical Research Fellow at the University of Oxford and held various roles at Tartu University Hospital. Her diverse experience spans multiple organizations and countries, reflecting her extensive expertise in rheumatology.